The effect of hepatic stimulatory substance, isolated from regenerating hepatic cytosol, and 50,000 and 300,000 subfractions in enhancing survival in experimental acute hepatic failure in rats treated with D‐galactosamine

Antonio Francavilla, Alfredo Dileo, Lorenzo Polimeno, Judith Gavaler, Riccardo Pellicci, Satoro Todo, Igal Kam, John Prelich, Leonard Makowka, Thomas E. Starzl – 1 November 1986 – Galactosamine induces a dose‐dependent hepatic injury in rats and many other animals. The toxicity of D‐galactosamine appears to be a consequence of the loss of hepatic UTP. It has previously been reported that regenerating liver cytosol is able to prevent, at least in part, the lethal effect of this substance by stimulating hepatic regeneration.

A pilot study on the effects of prednisone withdrawal on serum hepatitis B virus DNA and HBeAg in chronic active hepatitis B

Prem V. Nair, Myron J. Tong, Douglas Stevenson, Deborah Roskamp, Cissy Boone – 1 November 1986 – We investigated the efficacy of a short course of prednisone therapy in 20 patients with histologic evidence of chronic active hepatitis B. Sixteen of 20 prednisone‐treated patients who were initially serum hepatitis B virus DNA‐positive had a transient elevation of their serum ALT activity on withdrawal of prednisone. Subsequently, 14 of these 16 patients (87.5%) became persistently negative for serum hepatitis B virus DNA, and 10 also lost their HBeAg.

Portal venous flow in response to acute β‐blocker and vasodilatatory treatment in patients with liver cirrhosis

Marco Zoli, Giulio Marchesini, Alessandra Brunori, Maria Rita Cordiani, Emilio Pisi – 1 November 1986 – The drugs currently under investigation in the prevention of recurrent gastrointestinal bleeding in cirrhosis are likely to decrease the portal pressure by means of a primary reduction of portal blood flow. The hemodynamic effects of β‐blocking agents and vasodilatory drugs were noninvasively measured in eight patients with cirrhosis by means of pulsed echo‐doppler equipment.

Costs of liver transplantation: Primum non obfuscare

Laurence F. McMahon – 1 November 1986 – The costs and benefits of liver transplantation in adult patients at the University of Pittsburgh were reviewed for the period from 1981 through 1984. Indirect costs such as those to support the surgical and hepatology programs, the operating rooms and the clinical pathology department were ignored, and only those costs generated by the liver transplant program were considered in this analysis. Benefits to the patients are survival itself.

Effect of growth hormone on alcohol dehydrogenase activity in hepatocyte culture

Esteban Mezey, James J. Potter, Deborah L. Rhodes – 1 November 1986 – The effect of growth hormone on the activity of alcohol dehydrogenase was determined in hepatocyte culture from normal and hypophysectomized male rats. Alcohol dehydrogenase activity was highest in hepatocytes harvested from hypophysectomized rats. The enzyme activity remained stable in hepatocytes harvested from normal rats during 2 to 6 days of culture but declined steadily in hepatocytes cultured from hypophysectomized rats.

The effects of ethanol and hyperosmotic perfusates on albumin synthesis and release

Marcus A. Rothschild, Murray Oratz, Sidney S. Schreiber, Joseph Mongelli – 1 November 1986 – Sucrose and ethanol inhibit albumin synthesis; sucrose via an osmotic mechanism and ethanol during its metabolism. The present study was undertaken to compare the effects of both of these agents on albumin synthesis and secretion, and to see if ethanol inhibition could be related to an osmotic effect.

Brainstem auditory evoked potentials in hepatic encephalopathy

Sien‐Sing Yang, Nai‐Shin Chu, Yun‐Fan Liaw – 1 November 1986 – Brainstem auditory evoked potentials were obtained from 30 patients primarily with viral hepatitis to determine the functional status of the brainstem in hepatic encephalopathy. The patients were divided into four groups: Group 1 with compensated hepatic diseases; Group 2 with hepatic failure but no hepatic encephalopathy; Group 3 with Grade 1 or 2 hepatic encephalopathy, and Group 4 with Grade 3 or 4 hepatic encephalopathy.

Medium‐chain and long‐chain acyl CoA dehydrogenase deficiency: Clinical, pathologic and ultrastructural differentiation from Reye's syndrome

William R. Treem, Camillus A. Witzleben, David A. Piccoli, Charles A. Stanley, Daniel E. Hale, Paul M. Coates, John B. Watkins – 1 November 1986 – The clinical and pathologic findings in 12 patients with medium‐chain acyl CoA dehydrogenase deficiency and three patients with long‐chain acyl CoA dehydrogenase deficiency are summarized. Although these inborn errors of intramitochondrial β‐oxidation of fatty acids present with similar findings to Reye's syndrome, there are clinical, laboratory and hepatic histologic differences.

Subscribe to